Nisha Pandey

84% Cancer Patients Report Benefit From Ivermectin-Mebendazole: What The Study Found & Why More Trials Are Needed

The potential benefits of <span>Ivermectin</span> and <span>Mebendazole</span>, two anti-parasitic drugs, for <span><a href="https://www.healthandme.com/health/cancer">cancer</a></span> treatment have sparked a debate. 

A recent real-world study stated that an astonishing 84.4% clinical benefit rate was reported among cancer patients who took these two drugs together. But the number does not mean that 84% of the patients improved with the help of thesedrugs. The findings come with significant limitations. 

<h2><span rel="noindex">Ivermectin-Mebendazole</span>'s Effects On Cancer Patients </h2>

Published in Anticancer Research in June 2026, the study followed 197 cancer patients who had been prescribed ivermectin and mebendazole off-label through a US telemedicine platform. 

The patients received compounded capsules containing 25 mg of ivermectin and 250 mg of mebendazole. But only 122 patients, or 61.9%, completed the six-month follow-up. 

Among those who completed follow-up, 48.4% of the patients had no tumour regression or no sign of the disease. Another 36.1% showed no change, while in 15.6% of the patients, the disease had progressed. This generated the study's 84.4% Clinical Benefit Ratio. 

So, the number should not be interpreted as 84% of patients had their cancer tumours shrink or the disease disappeared. 

The researchers also reported that 25.4% of participants faced side effects, most of which were mild and mainly gastrointestinal. 

It is also important to note that patients were also receiving other treatments, including chemotherapy, radiation, and surgery, while nearly half reported using supplements. Many also made changes to their diets.

Also read: <a href="https://www.healthandme.com/health-news/daraxonrasib-new-drug-approved-for-pancreatic-cancer-shows-promise-in-lung-cancer-treatment-article-156033525" data-type="tilCustomLink">Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment</a> 

This was a prospective observational study, not a randomised controlled clinical trial. There was no comparison group receiving standard treatment or a placebo. 

The cancer results were also self-reported through digital surveys rather than independently verified as part of the study. 

That makes it impossible to determine whether ivermectin and mebendazole caused the reported improvements. 

Patients were also receiving other cancer treatments and making changes to their diets or taking supplements. These factors could have influenced the outcomes. 

<em>PubMed </em>currently carries an 'Expression of Concern' for the paper, dated June 9, 2026. The study's own authors describe their findings as “hypothesis-generating” and say randomized controlled trials are needed.

Also read: <a href="https://www.healthandme.com/health-wellness/blocked-ears-after-flight-turned-out-to-be-rare-head-and-neck-cancer-in-22-year-old-article-156032105" data-type="tilCustomLink">Blocked Ears After Flight Turned Out To Be Rare Head And Neck Cancer In 22-Year-Old</a> 

Researchers are also exploring whether ivermectin can be delivered to <a href="https://www.healthandme.com/health-wellness/the-silent-killer-why-more-indians-need-to-pay-attention-to-liver-cancer-article-155998015" data-type="tilCustomLink">brain tumours</a> through the nose. 

In a study in rats with glioma, ivermectin packed inside tiny nanocapsules and given through the nose reduced tumour size after 10 days. 

The nano-formulation performed better than regular ivermectin, while another silica-based formulation did not have the same effect on the rats. 

The idea is to use the nose as a possible route to help drugs reach the brain, where the blood-brain barrier can make drug delivery difficult. 

However, this was an animal study. The results therefore show a potential research direction, not definite evidence that nasal ivermectin can treat <a href="https://www.healthandme.com/health-news/new-clinical-trial-shows-promise-in-non-surgical-treatment-of-early-stage-rectal-cancer-article-155995635" data-type="tilCustomLink">brain cancer</a> in humans.

Also read: <a href="https://www.healthandme.com/health-news/nearly-8-in-10-us-young-adults-show-signs-of-heart-kidney-risk-why-early-checks-matter-article-156030923" data-type="tilCustomLink">Nearly 8 In 10 US Young Adults Show Signs Of Heart, Kidney Risk: Why Early Checks Matter</a> 

<h2>What Does The Evidence Say About <span rel="noindex">Fenbendazole</span>? </h2>

Healthy and Hearty Picks: Cancer Cases Rising in India | Causes, New Treatments & Prevention

<a href="https://www.healthandme.com/health-news/trump-strikes-drug-pricing-deals-with-9-more-drug-makers-will-americans-finally-pay-less-for-medicines-article-156022672" data-type="tilCustomLink">Fenbendazole</a> has also generated similar interest because laboratory studies have suggested that it can interfere with processes cancer cells need to survive, including microtubule function and cellular metabolism. 

A 2025 case series described three people with advanced breast, prostate and melanoma cancers who self-administered fenbendazole alongside other treatments. The report described complete or near-complete remissions. 

However, that paper was subsequently retracted in January 2026. <em>PubMed </em>now lists the retraction, making the original case series unsuitable as reliable evidence that fenbendazole treats cancer. 

The study provides possible cancer treatment options that can be investigated treatment as they are not proven yet. 

A 2025 review highlighted several possible anticancer mechanisms for ivermectin, including effects on YAP1, Wnt/TCF and AKT/mTOR signalling, oxidative stress and apoptosis. 

But the review also noted that the human cases it examined were not designed to test ivermectin as a cancer treatment. So as of now, there is no robust clinical evidence that says ivermectin, mebendazole or fenbendazole as effective cancer treatments. 

For cancer patients, these drugs should not be substituted for established treatment on the basis of these studies alone.

Health Conditions A-Z

health

84-cancer-patients-report-benefit-from-ivermectin-mebendazole-what-the-study-found-why-more-trials-are-needed

ivermectin

mebendazole

fenbendazole

brain cancer researchers

ivermectin-mebendazole

cancer

anti parasitic drugs

how-an-inactive-lifestyle-is-damaging-your-knees

How An Inactive Lifestyle Is Damaging Your Knees

credit-ai

Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The potential benefits of Ivermectin and Mebendazole, two anti-parasitic drugs, for cancer treatment have sparked a debate. A recent real-world study stated that an astonishing 84.4% clinical benefit rate was reported among cancer patients who took these two drugs together. But the number does not mean that 84% of the patients improved with the help of thesedrugs. The findings come with significant limitations. Ivermectin-Mebendazole's Effects On Cancer Patients Published in Anticancer Research in June 2026, the study followed 197 cancer patients who had been prescribed ivermectin and mebendazole off-label through a US telemedicine platform. The patients received compounded capsules containing 25 mg of ivermectin and 250 mg of mebendazole. But only 122 patients, or 61.9%, completed the six-month follow-up. Among those who completed follow-up, 48.4% of the patients had no tumour regression or no sign of the disease. Another 36.1% showed no change, while in 15.6% of the patients, the disease had progressed. This generated the study's 84.4% Clinical Benefit Ratio. So, the number should not be interpreted as 84% of patients had their cancer tumours shrink or the disease disappeared. The researchers also reported that 25.4% of participants faced side effects, most of which were mild and mainly gastrointestinal. It is also important to note that patients were also receiving other treatments, including chemotherapy, radiation, and surgery, while nearly half reported using supplements. Many also made changes to their diets.Also read: Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment The Study Has Limitations This was a prospective observational study, not a randomised controlled clinical trial. There was no comparison group receiving standard treatment or a placebo. The cancer results were also self-reported through digital surveys rather than independently verified as part of the study. That makes it impossible to determine whether ivermectin and mebendazole caused the reported improvements. Patients were also receiving other cancer treatments and making changes to their diets or taking supplements. These factors could have influenced the outcomes. PubMed currently carries an 'Expression of Concern' for the paper, dated June 9, 2026. The study's own authors describe their findings as “hypothesis-generating” and say randomized controlled trials are needed.Also read: Blocked Ears After Flight Turned Out To Be Rare Head And Neck Cancer In 22-Year-Old Ivermectin And Brain Cancer Researchers are also exploring whether ivermectin can be delivered to brain tumours through the nose. In a study in rats with glioma, ivermectin packed inside tiny nanocapsules and given through the nose reduced tumour size after 10 days. The nano-formulation performed better than regular ivermectin, while another silica-based formulation did not have the same effect on the rats. The idea is to use the nose as a possible route to help drugs reach the brain, where the blood-brain barrier can make drug delivery difficult. However, this was an animal study. The results therefore show a potential research direction, not definite evidence that nasal ivermectin can treat brain cancer in humans.Also read: Nearly 8 In 10 US Young Adults Show Signs Of Heart, Kidney Risk: Why Early Checks Matter What Does The Evidence Say About Fenbendazole?       Fenbendazole has also generated similar interest because laboratory studies have suggested that it can interfere with processes cancer cells need to survive, including microtubule function and cellular metabolism. A 2025 case series described three people with advanced breast, prostate and melanoma cancers who self-administered fenbendazole alongside other treatments. The report described complete or near-complete remissions. However, that paper was subsequently retracted in January 2026. PubMed now lists the retraction, making the original case series unsuitable as reliable evidence that fenbendazole treats cancer. The study provides possible cancer treatment options that can be investigated treatment as they are not proven yet. A 2025 review highlighted several possible anticancer mechanisms for ivermectin, including effects on YAP1, Wnt/TCF and AKT/mTOR signalling, oxidative stress and apoptosis. But the review also noted that the human cases it examined were not designed to test ivermectin as a cancer treatment. So as of now, there is no robust clinical evidence that says ivermectin, mebendazole or fenbendazole as effective cancer treatments. For cancer patients, these drugs should not be substituted for established treatment on the basis of these studies alone.

84% cancer patients report benefit from ivermectin-mebendazole: what the study found & why more trials are needed

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

84% Cancer Patients Report Benefit From Ivermectin-Mebendazole: What The Study Found & Why More Trials Are Needed

Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment

Mandatory Testosterone Screening For US Troops Over 30 Begins Immediately: When Is Low Testosterone A Concern?

GLP-1 Drug Semaglutide Extends Lifespan In Healthy Older Mice By 12%, Study Finds

Health Conditions A-Z

How An Inactive Lifestyle Is Damaging Your Knees

84% Cancer Patients Report Benefit From Ivermectin-Mebendazole: What The Study Found & Why More Trials Are Needed

Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment

84% Cancer Patients Report Benefit From Ivermectin-Mebendazole: What The Study Found & Why More Trials Are Needed

Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment

​​Mandatory Testosterone Screening For US Troops Over 30 Begins Immediately: When Is Low Testosterone A Concern?

GLP-1 Drug Semaglutide Extends Lifespan In Healthy Older Mice By 12%, Study Finds

Health Conditions A-Z

How An Inactive Lifestyle Is Damaging Your Knees

84% Cancer Patients Report Benefit From Ivermectin-Mebendazole: What The Study Found & Why More Trials Are Needed

Daraxonrasib: New Drug Approved For Pancreatic Cancer Shows Promise In Lung Cancer Treatment

Mandatory Testosterone Screening For US Troops Over 30 Begins Immediately: When Is Low Testosterone A Concern?